Standout Papers

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials 2018 2026 2020 2023 236
  1. Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials (2018)
    Julio Rosenstock, Jan Marquard et al. Diabetes Care

Immediate Impact

1 from Science/Nature 56 standout
Sub-graph 1 of 23

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
New advances in type 1 diabetes
2024 Standout
1 intermediate paper

Works of Jan Marquard being referenced

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
2018 Standout
Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review
2017

Author Peers

Author Last Decade Papers Cites
Jan Marquard 635 408 112 214 28 768
Jean-Louis Sélam 659 415 98 247 22 929
Klaus Kølendorf 642 328 187 141 49 883
A. Starke 478 323 134 129 29 872
Evgenia Gourgari 528 304 141 221 37 814
Robert C. Northcutt 406 258 149 184 30 919
Katherine Lord 533 224 103 153 31 727
E. Bognetti 410 303 61 344 28 706
Paola Sindaco 723 418 152 275 28 932
Philip M. LeCompte 403 458 106 387 20 901
R. W. Bilous 527 184 100 144 21 832

All Works

Loading papers...

Rankless by CCL
2026